Covidien participates in the Series A round for Fire1, a stealthy Irish medical device startup that could be a player in the vascular space.
Covidien said it participated in the Series A round for stealthy Irish medical device startup Fire1.
Dublin-based Fire1 is developing "novel therapeutic devices" to "address certain unmet medical needs," according to a press release. No further information on its focus or on the details of the funding round were provided, although Covidien vascular therapies president Stacy Enxing Seng will serve on the Fire1 board, suggesting that the startup might play in the vascular space.
Lightstone Ventures and New Enterprise Associates also participated in the round, according to a press release.